Benefit and cost of repeating a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) polymerase chain reaction (PCR) test after the second day of hospitalization in five hospitals during various community prevalences and vaccination rates
Department
Medicine
Document Type
Article
Publication Title
Infection Control and Hospital Epidemiology
Abstract
At our hospital, universal severe acute respiratory coronavirus virus 2 (SARS-CoV-2) polymerase chain reaction (PCR) testing was performed upon admission and again after 2 inpatient days. As community-wide prevalence, admission, and vaccination rates varied, the number needed to benefit fluctuated between 16 and 769 and the cost per additional detection fluctuated between $800 and $29,400. These 2 metrics were negatively associated with new hospital admissions. No other community indicator was associated with the number needed to benefit and cost per additional detection.
First Page
106
Last Page
109
DOI
10.1017/ice.2022.157
Volume
44
Issue
1
Publication Date
1-2023
PubMed ID
35705231
Recommended Citation
Bulnes, R., Said, M., Bronstein, M., Gutowski, J., Alag, K., Bress, J., Dellefave, A., Riedy, D., Alcantara, J., Bhavsar, H., Gargano, B., & Lesho, E. (2023). Benefit and cost of repeating a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) polymerase chain reaction (PCR) test after the second day of hospitalization in five hospitals during various community prevalences and vaccination rates. Infection Control and Hospital Epidemiology, 44 (1), 106-109. https://doi.org/10.1017/ice.2022.157
Comments
Record updated with published article citation 2023-01-26 LB.
Published online ahead of print 2022-06-16.